Commercial Moderna builds commercial muscle as new launches loom PharmaphorumModerna expands its commercial team, as the FDA issues a mostly positive briefing document on its seasonal flu shot, due to face an adcomm tomorrow.Read full story pharminent June 17, 2026 (Last updated: June 17, 2026) Pharmaphorum Moderna expands its commercial team, as the FDA issues a mostly positive briefing document on its seasonal flu shot, due to face an adcomm tomorrow. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Altaris to acquire Simulations Plus in $375m all-cash dealNext: Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact Related Stories Commercial ADA ’26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option pharminent June 8, 2026 Commercial Lilly and Novo face off at ADA 2026 as others seek to compete in obesity pharminent June 5, 2026 Commercial CVS obesity drug deal puts Lilly on equal footing with Novo pharminent May 28, 2026
